Cryo-Cell International Inc
Veridion Score
BETAMEDIUM CONF · 5/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is CCEL moving today?
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
CCEL overview
Related filings and maps
Congress activity in CCEL
No receipt-qualified Congressional disclosure is present for CCEL in the cached public ledger.
CCEL contract awards, year to date.
Public federal awards linked to this ticker.
CCEL lobbying filings, year to date.
Registered lobbying filings matched to Cryo-Cell International Inc.